Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 19/20 | 0.37 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | POLA1 | P09884 | 1/20 | 0.36 |
| ▸ | POLD1 | P28340 | 1/20 | 0.36 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272516 | 0.88 | P2RY2 (0.36) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL24225941 | 0.87 | FBP1 (0.42) | — | |
| SCHEMBL271873 | 0.86 | P2RY2 (0.35) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL272694 | 0.85 | P2RY2 (0.37) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL18462970 | 0.85 | P2RY2 (0.35) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL271833 | 0.85 | P2RY2 (0.37) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL21506757 | 0.84 | POLB (0.39) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL21555520 | 0.84 | P2RY2 (0.37) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL22002630 | 0.84 | P2RY2 (0.37) | P2RY2P2RY4POLBPOLA1POLD1 | |
| SCHEMBL21555519 | 0.84 | P2RY2 (0.37) | P2RY2P2RY4POLBPOLA1POLD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2294076-B1 | CHEMICALLY MODIFIED NUCLEOSIDE 5'-TRIPHOSPHATES FOR THERMALLY INITIATED REPLICATION OF NUCLEIC ACID | TRILINK BIOTECHNOLOGIES (US) | 2017-03-08 | — | — | EP | disclosed |
| US-8133669-B2 | Chemically modified nucleoside 5′-triphosphates for thermally initiated amplification of nucleic acid | TRILINK BIOTECHNOLOGIES (US) | 2012-03-13 | — | — | US | disclosed |
| US-8133669-B2 | Chemically modified nucleoside 5′-triphosphates for thermally initiated amplification of nucleic acid | TRILINK BIOTECHNOLOGIES (US) | 2012-03-13 | — | — | US | disclosed |
| US-20100003724-A1 | CHEMICALLY MODIFIED NUCLEOSIDE 5'-TRIPHOSPHATES FOR THERMALLY INITIATED AMPLIFICATION OF NUCLEIC ACID | TriLink Bio Technologies | 2010-01-07 | — | — | US | disclosed |
| US-20100003724-A1 | CHEMICALLY MODIFIED NUCLEOSIDE 5'-TRIPHOSPHATES FOR THERMALLY INITIATED AMPLIFICATION OF NUCLEIC ACID | TriLink Bio Technologies | 2010-01-07 | — | — | US | disclosed |